Dan Yan Selected Research

Dan Yan Research Topics

Disease

45	Neoplasms (Cancer) 03/2024 - 09/2008
20	Inflammation (Inflammations) 03/2024 - 10/2013
13	Type 2 Diabetes Mellitus (MODY) 01/2024 - 05/2015
11	Insulin Resistance 07/2023 - 12/2014
9	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024 - 01/2018
7	Fibrosis (Cirrhosis) 03/2024 - 10/2013
7	Atherosclerosis 01/2024 - 04/2010
7	Infections 08/2023 - 01/2015
6	Myocardial Ischemia (Ischemic Heart Diseases) 01/2018 - 04/2013
5	Hypoxia (Hypoxemia) 11/2023 - 01/2016
5	Ischemia 08/2023 - 08/2010
5	Body Weight (Weight, Body) 07/2023 - 08/2017
5	Obesity 07/2023 - 01/2018
5	COVID-19 11/2022 - 01/2020
5	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2018
5	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020 - 11/2017
4	Wounds and Injuries (Trauma) 12/2023 - 12/2020
4	Dysbiosis 07/2023 - 01/2018
4	Diabetic Cardiomyopathies 01/2023 - 03/2016
4	Myocardial Infarction 11/2019 - 09/2011
3	Corneal Injuries 03/2024 - 01/2023
3	Metabolic Diseases (Metabolic Disease) 01/2024 - 01/2023
3	Pain (Aches) 12/2023 - 08/2015
3	Stroke (Strokes) 07/2023 - 01/2018
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2023 - 12/2020
3	Diabetes Mellitus 01/2023 - 01/2017
3	Drug-Related Side Effects and Adverse Reactions 05/2022 - 09/2011
3	Hyperglycemia 01/2022 - 12/2014
3	Esophageal Squamous Cell Carcinoma 03/2021 - 01/2019
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 04/2010
3	Breast Neoplasms (Breast Cancer) 01/2017 - 07/2009
2	Non-alcoholic Fatty Liver Disease 03/2024 - 01/2018
2	Vision Disorders (Hemeralopia) 12/2023 - 08/2023
2	Burns 12/2023 - 12/2020
2	Hypersensitivity (Allergy) 11/2023 - 11/2022
2	Diabetic Nephropathies (Diabetic Nephropathy) 10/2023 - 01/2020
2	Medulloblastoma 01/2023 - 03/2020
2	Hypertension (High Blood Pressure) 01/2022 - 01/2021

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2023 - 07/2010
11	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 12/2014
8	Blood Glucose (Blood Sugar)IBA 01/2023 - 01/2018
8	Interleukin-6 (Interleukin 6)IBA 02/2021 - 01/2017
8	MicroRNAs (MicroRNA)IBA 01/2020 - 07/2010
7	Insulin (Novolin)FDA Link 09/2022 - 12/2014
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2018
5	BerberineIBA 01/2024 - 01/2014
5	HydrogelsIBA 12/2023 - 02/2019
5	Messenger RNA (mRNA)IBA 01/2023 - 01/2019
5	Methotrexate (Mexate)FDA LinkGeneric 03/2020 - 11/2017
4	Phosphotransferases (Kinase)IBA 03/2024 - 01/2018
4	c-Mer Tyrosine KinaseIBA 03/2024 - 12/2018
4	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2023 - 10/2015
4	CytokinesIBA 09/2022 - 10/2015
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2022 - 09/2008
4	bazedoxifeneIBA 02/2021 - 03/2019
4	RNA (Ribonucleic Acid)IBA 01/2021 - 10/2015
4	Raloxifene Hydrochloride (Evista)FDA Link 01/2021 - 01/2017
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2020 - 09/2011
4	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2020 - 05/2017
4	Antiviral Agents (Antivirals)IBA 01/2017 - 06/2015
3	Anti-Bacterial Agents (Antibiotics)IBA 02/2024 - 10/2021
3	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 08/2007
3	Apolipoproteins E (ApoE)IBA 01/2024 - 11/2020
3	Drug CombinationsIBA 01/2024 - 01/2020
3	Amino Acids FDA Link 12/2023 - 01/2022
3	Glycoproteins (Glycoprotein)IBA 12/2023 - 03/2019
3	Tyrosine Kinase InhibitorsIBA 10/2023 - 12/2018
3	Capsules (Microcapsules)IBA 10/2023 - 01/2020
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 01/2021
3	LigandsIBA 01/2022 - 09/2008
3	Therapeutic UsesIBA 01/2022 - 01/2014
3	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022 - 05/2015
3	ApolipoproteinsIBA 02/2021 - 01/2018
2	tyrosine receptor (receptor, tyrosine)IBA 03/2024 - 11/2021
2	AlkaliesIBA 12/2023 - 12/2020
2	Carrier Proteins (Binding Protein)IBA 12/2023 - 01/2019
2	SolutionsIBA 12/2023 - 03/2014
2	Hemoglobins (Hemoglobin)IBA 11/2023 - 06/2020
2	Oxygen (Dioxygen)IBA 11/2023 - 01/2022
2	Contrast MediaIBA 11/2023 - 01/2022
2	16S Ribosomal RNAIBA 07/2023 - 01/2018
2	Hematoxylin (Haematoxylon)IBA 07/2023 - 09/2022
2	Eosine Yellowish-(YS) (Eosin)IBA 07/2023 - 09/2022
2	Oxidoreductases (Dehydrogenase)IBA 01/2023 - 01/2021
2	Monoclonal AntibodiesIBA 01/2023 - 01/2023
2	Circular RNAIBA 01/2023 - 01/2022
2	LipopolysaccharidesIBA 09/2022 - 08/2019
2	poly-N-isopropylacrylamideIBA 05/2022 - 02/2019
2	CholesterolIBA 01/2022 - 06/2014
2	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 03/2021

Therapy/Procedure

36	Therapeutics 01/2024 - 04/2010
5	Drug Therapy (Chemotherapy) 01/2023 - 10/2015
5	Photochemotherapy (Photodynamic Therapy) 01/2023 - 10/2015
4	Immunotherapy 10/2023 - 01/2021
4	Chinese Traditional Medicine (Traditional Chinese Medicine) 09/2022 - 01/2020
4	Precision Medicine 01/2022 - 08/2019
4	Injections 10/2021 - 09/2011
2	Radiotherapy 01/2023 - 07/2010
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022 - 01/2019
2	Aftercare (After-Treatment) 01/2022 - 12/2018